logo

DRMA

Dermata TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

DRMA Profile

Dermata Therapeutics, Inc.

A clinical-stage biotech company focusing on the treatment of medical and aesthetic skin conditions

Pharmaceutical
--
08/13/2021
NASDAQ Stock Exchange
8
12-31
Common stock
3525 Del Mar Heights Rd., #322, San Diego, CA 92130
--
Dermata Therapeutics, Inc., in Delaware in December 2014. They are a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative drug candidates for the treatment of medical and aesthetic skin diseases and conditions, which the company believes represent a significant market opportunity due to the lack or non-existence of current therapies.